@article{TLCR23560,
author = {Motonobu Saito and Koji Kono and Takashi Kohno},
title = {Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {Molecular targeted therapy against driver gene aberrations has a significantly high positive response rate compared with traditional cytotoxic chemotherapies, and has thus dramatically changed the treatment strategies for malignant tumors, including non-small cell lung cancer (NSCLC) (1). Lung adenocarcinoma (LADC) can be treated with targeted therapy against driver gene aberrations using tyrosine kinase inhibitors (TKIs).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23560}
}